EPO Patents = 1

Forward Citations = 4

Loading Chart...

7 inventors (with patents filed for the assignee):

Thomas R DiRaimondo (6 out of 6 patents)

David Alan Campbell (4 out of 25 patents)

Ramesh Bhatt (3 out of 3 patents)

4. David Campbell (3 out of 3 patents)

5. William J Dower (1 out of 77 patents)

6. Steven E Cwirla (1 out of 39 patents)

7. Blake M Williams (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 12734208 - MODIFIED ANTIBODIES (2026-09-15),

2. 12723099 - TUMOR ACTIVATED ANTIBODIES TARGETING TROP2 AND USES THEREOF (2026-09-01),

3. 12617865 - COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARGETING PSMA AND EFFECTOR CELL ANTIGENS (2026-05-05),

4. 12433953 - Compositions and methods related to tumor activated antibodies targeting EGFR and effector cell antigens (2025-10-07),

5. 12161724 - Compositions and methods related to tumor activated antibodies targeting EGFR and effector cell antigens (2024-12-10),

6. 11555078 - Compositions and methods related to tumor activated antibodies targeting PSMA and effector cell antigens (2023-01-17),

7. 11512113 - Cleavable linker compositions and methods (2022-11-29),

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

7 Patents

#702 in San Diego, CA

#9,491 in California

#39,879 in US

San Diego, CA, United States of America

Janux Therapeutics, Inc.

Forward Citations = 4

7 inventors:

Thomas R DiRaimondo (6 out of 6 patents)

David Alan Campbell (4 out of 25 patents)

Ramesh Bhatt (3 out of 3 patents)

4. David Campbell (3 out of 3 patents)

5. William J Dower (1 out of 77 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Janux Therapeutics, Inc.. Retrieved from https://idiyas.com/company/janux-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]